1 Min Read
Sept 21 (Reuters) - Merck KGaA:
* European commission approves Bavencio (avelumab) for metastatic Merkel cell carcinoma For the full story: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.